483
Rpk Pharmaceuticals IncFDA 483 - Rpk Pharmaceuticals Inc - October 14, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of RPK Pharmaceuticals Inc, a drug repackaging/relabeling facility in Union City, CA, revealed significant deficiencies. The firm failed to follow written procedures for handling expired products and maintaining reserved samples. Additionally, cleaning and maintenance procedures for equipment were found to be deficient, with expired cleaning supplies observed in use.
Open in Dashboard
ID · ee539f9e-8088-44ee-9bc1-4548c62fb828